Redox-activated MRI contrast agents based on lanthanide and transition metal ions

详细信息    查看全文

• 作者：Pavel B. Tsitovich ; Patrick J. Burns ; Adam M. McKay ; Janet R. Morrow ; ^{jmorrow@buffalo.edu" class="auth_mail}
• 关键词：Magnetic resonance imaging ; Lanthanide ; Iron ; Cobalt ; Manganese ; redox
• 刊名：Journal of Inorganic Biochemistry
• 出版年：April, 2014
• 年：2014
• 卷：133
• 期：Complete
• 页码：143-154
• 全文大小：1760 K

文摘

The reduction/oxidation (redox) potential of tissue is tightly regulated in order to maintain normal physiological processes, but is disrupted in disease states. Thus, the development of new tools to map tissue redox potential may be clinically important for the diagnosis of diseases that lead to redox imbalances. One promising area of chemical research is the development of redox-activated probes for mapping tissue through magnetic resonance imaging (MRI). In this review, we summarize several strategies for the design of redox-responsive MRI contrast agents. Our emphasis is on both lanthanide(III) and transition metal(II/III) ion complexes that provide contrast either as T₁ relaxivity MRI contrast agents or as paramagnetic chemical exchange saturation transfer (PARACEST) contrast agents. These agents are redox-triggered by a variety of chemical reactions or switches including redox-activated thiol groups, and heterocyclic groups that interact with the metal ion or influence properties of other ancillary ligands. Metal ion centered redox is an approach which is ripe for development by coordination chemists. Redox-triggered metal ion approaches have great potential for creating large differences in magnetic properties that lead to changes in contrast. An attractive feature of these agents is the ease of fine-tuning the metal ion redox potential over a biologically relevant range.